DUSP6: A Potential Drug Target and Biomarker (G1848)

Target Name: DUSP6

NCBI ID: G1848

DUSP6

DUSP6: A Potential Drug Target and Biomarker

DUSP6, short for Dusprinterin-conjugated superparametrized phosphorositide 6, is a protein that is expressed in various tissues and cells in the human body. Its function is not well understood, but research has shown that it plays a role in several cellular processes, including cell signaling, inflammation, and neurodegeneration. As a result, DUSP6 has emerged as a potential drug target and biomarker for a variety of diseases.

DUSP6 is a protein that is composed of several domains, including an N-terminal transmembrane domain, a src-like tyrosine kinase domain, and a C-terminal Ser-proteinase domain. The N-terminal transmembrane domain is responsible for the protein's ability to transmit signals across the cell membrane, while the src-like tyrosine kinase domain is responsible for the protein's ability to interact with other signaling molecules. The C-terminal Ser-proteinase domain is responsible for the protein's ability to hydrolyze and cross-link other proteins, which is a key aspect of its role in cell signaling.

One of the most significant functions of DUSP6 is its role in cell signaling. DUSP6 has been shown to play a role in several signaling pathways, including the PI3K/Akt signaling pathway and the TGF-β signaling pathway. In these pathways, DUSP6 is involved in the regulation of cellular signaling, and is shown to play a negative role in the development of cancer.

In addition to its role in cell signaling, DUSP6 has also been shown to play a role in inflammation. DUSP6 has been shown to be involved in the regulation of inflammatory responses, and is shown to play a negative role in the development of chronic inflammation. This suggests that DUSP6 may be a potential therapeutic target for diseases that are characterized by chronic inflammation, such as cancer, autoimmune diseases, and neurodegenerative diseases.

DUSP6 has also been shown to play a role in neurodegeneration. DUSP6 has been shown to be involved in the regulation of neurotransmitter release from neurons, and is shown to play a negative role in the development of neurodegenerative diseases. This suggests that DUSP6 may be a potential therapeutic target for diseases that are characterized by neurodegeneration, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease.

DUSP6 has also been shown to play a role in the regulation of cell division and apoptosis. DUSP6 has been shown to be involved in the regulation of cell division, and is shown to play a positive role in the survival of cancer cells. This suggests that DUSP6 may be a potential therapeutic target for diseases that are characterized by uncontrolled cell division, such as cancer. Additionally, DUSP6 has also been shown to play a role in the regulation of apoptosis, and is shown to play a positive role in the survival of cancer cells. This suggests that DUSP6 may be a potential therapeutic target for diseases that are characterized by apoptosis, such as cancer.

DUSP6 has also been shown to play a role in the regulation of cellular signaling and inflammation. DUSP6 has been shown to play a role in the regulation of cellular signaling, and is shown to have a negative impact on the development of cancer. Additionally, DUSP6 has also been shown to play a role in the regulation of inflammation, and is shown to have a negative impact on the development of chronic inflammation. This suggests that DUSP6 may be a potential therapeutic target for diseases that are characterized by chronic inflammation, such as cancer and autoimmune diseases.

In conclusion, DUSP6 is a protein that is expressed in various tissues and cells in the human body, and has been shown to play a role in several cellular processes, including cell signaling, inflammation,

Protein Name: Dual Specificity Phosphatase 6

Functions: Inactivates MAP kinases. Has a specificity for the ERK family (PubMed:9858808). Plays an important role in alleviating chronic postoperative pain. Necessary for the normal dephosphorylation of the long-lasting phosphorylated forms of spinal MAPK1/3 and MAP kinase p38 induced by peripheral surgery, which drives the resolution of acute postoperative allodynia (By similarity). Also important for dephosphorylation of MAPK1/3 in local wound tissue, which further contributes to resolution of acute pain (By similarity). Promotes cell differentiation by regulating MAPK1/MAPK3 activity and regulating the expression of AP1 transcription factors (PubMed:29043977)

The "DUSP6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets